1. CC2D1A regulates human intellectual and social function as well as NF-κB signaling homeostasis.
- Author
-
Manzini MC, Xiong L, Shaheen R, Tambunan DE, Di Costanzo S, Mitisalis V, Tischfield DJ, Cinquino A, Ghaziuddin M, Christian M, Jiang Q, Laurent S, Nanjiani ZA, Rasheed S, Hill RS, Lizarraga SB, Gleason D, Sabbagh D, Salih MA, Alkuraya FS, and Walsh CA
- Subjects
- Animals, Cells, Cultured, Child Development Disorders, Pervasive metabolism, DNA-Binding Proteins genetics, Homeostasis, Humans, Intellectual Disability metabolism, Mice, Mutation, Neurons cytology, Pedigree, Repressor Proteins genetics, Repressor Proteins metabolism, Seizures metabolism, Signal Transduction, Child Development Disorders, Pervasive genetics, DNA-Binding Proteins metabolism, Intellectual Disability genetics, NF-kappa B metabolism, Neurons metabolism, Seizures genetics
- Abstract
Autism spectrum disorder (ASD) and intellectual disability (ID) are often comorbid, but the extent to which they share common genetic causes remains controversial. Here, we present two autosomal-recessive "founder" mutations in the CC2D1A gene causing fully penetrant cognitive phenotypes, including mild-to-severe ID, ASD, as well as seizures, suggesting shared developmental mechanisms. CC2D1A regulates multiple intracellular signaling pathways, and we found its strongest effect to be on the transcription factor nuclear factor κB (NF-κB). Cc2d1a gain and loss of function both increase activation of NF-κB, revealing a critical role of Cc2d1a in homeostatic control of intracellular signaling. Cc2d1a knockdown in neurons reduces dendritic complexity and increases NF-κB activity, and the effects of Cc2d1a depletion can be rescued by inhibiting NF-κB activity. Homeostatic regulation of neuronal signaling pathways provides a mechanism whereby common founder mutations could manifest diverse symptoms in different patients., (Copyright © 2014 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF